Close Menu

NEW YORK (GenomeWeb) – HTG Molecular Diagnostics has appealed a delisting determination by Nasdaq after the company's shares failed to regain compliance with a listing requirement, the firm said in a document filed with the US Securities and Exchange Commission after the close of the market on Tuesday.

The company had been warned in August 2016 by Nasdaq that it failed to comply with a minimum $10 million stockholder equity requirement to remain listed on the exchange. HTG Molecular was given an extension until Feb. 13 to regain compliance.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Lancet and the New England Journal of Medicine have issued expressions of concern regarding the data used in two COVID-19 papers, the New York Times reports. 

An Associated Press report says China refrained from releasing the SARS-CoV-2 genome for more than a week in January, frustrating the World Health Organization.

Researchers have sequenced the genome of the mayfly, garnering insight into how insects evolved wings, Science reports.

In Genome Research this week: gene expression in primate brain regions, inversions and breakpoint inverted repeats in the human genome, and more.